Nicotinamide as a potential addition to the anti-atopic dermatitis armamentarium.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Immunopharmacology

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.INTIMP.2003.11.008PMID 15135312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nicotinamide: a potential addition to the anti‐psoriatic weaponry

  2003cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• Increased oxidative stress in childhood atopic dermatitis.

  2001cited by this paper
• Cellular and immunologic mechanisms in atopic dermatitis.

  2001cited by this paper
• Pharmacologic alternatives for severe atopic dermatitis

  2001cited by this paper
• Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier

  2000cited by this paper
• Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-alpha in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes.

  2000cited by this paper
• Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies.

  1999cited by this paper
• Nicotinamide in type 1 diabetes. Mechanism of action revisited.

  1999cited by this paper
• Successful treatment of severe atopic dermatitis-complicated cataract and male infertility with a natural product antioxidant.

  1998cited by this paper
• Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study.

  1996cited by this paper
• Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients.

  1995cited by this paper
• Clinical Application of Nitric Oxide Synthase Inhibitor for Atopic Dermatitis

  1995cited by this paper
• Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages.

  1994cited by this paper
• Manual of Dermatologic Therapeutics

  1994cited by this paper
• Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers.

  1992cited by this paper
• Advanced Dermatologic Therapy

  1987cited by this paper
• The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report.

  1986cited by this paper
• Festschrift to Professor Lennox Eales

  1985cited by this paper
• Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.

  1982cited by this paper
• Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor.

  1976cited by this paper
• Inhibition by nicotinamide of an homologous PCA reaction and antigen-induced histamine release from rat peritoneal mast cells.

  1975cited by this paper
• THE BASIS OF ITCHING.

  1965cited by this paper
• THE BASIS OF ITCHING.

  1965cited by this paper

• Nano-Silica Particle Exposure Affects Pollen-Sensitized Mice via Nicotinamide Metabolism

  2025cites this paper
• Development of niacinamide loaded elastic liposome as a potential transepidermal delivery system

  2025cites this paper
• Eugenol-Loaded Transethosomal Gel for Improved Skin Delivery and Treatment of Atopic Dermatitis

  2024cites this paper
• Diagnosis and Treatment of Sensitive Skin Syndrome: An Algorithm for Clinical Practice

  2019cites this paper
• Diagnosis and Treatment of Sensitive Skin Syndrome: An Algorithm for Clinical Practice.

  2019cites this paper
• Skin permeation enhancement of nicotinamide through using fluidization and deformability of positively charged ethosomal vesicles: A new approach for treatment of atopic eczema

  2019cites this paper
• Nicotinamide: Mechanism of action and indications in dermatology

  2018cites this paper
• Higher maternal serum concentrations of nicotinamide and related metabolites in late pregnancy are associated with a lower risk of offspring atopic eczema at age 12 months

  2016cites this paper
• Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery

  2016cites this paper
• بررسی فاکتورهای نوروتروفیک در مدل حیوانی تخریب میلین القاء شده با کوپریزون در موشهای C57bl/6

  2016cites this paper
• Acute toxicity, biochemical and histopathological responses of endosulfan in Chanos chanos.

  2016cites this paper
• New innovation of moisturizers containing non-steroidal anti-inflammatory agents for atopic dermatitis

  2015cites this paper
• Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment.

  2014cites this paper
• Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

  2014cites this paper
• Nicotinamide and the skin

  2014cites this paper
• Investigation of different emulsion systems for dermal delivery of nicotinamide

  2013cites this paper
• How much do we really know about our favorite cosmeceutical ingredients?

  2010cites this paper
• GDAŃSKI UNIWERSYTET MEDYCZNY

  2009cites this paper
• METABOLITY NIKOTYNAMIDU I ICH ROLA W FIZJOLOGII I PATOLOGII CZŁOWIEKA

  2009cites this paper
• Nicotinamide in dermatology: a capsule summary

  2007cites this paper
• Nicotinamide – biologic actions of an emerging cosmetic ingredient

  2005cites this paper
• combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery

  year unknowncites this paper
• PRACTICAL DERMATOLOGY Diagnosis and Treatment of Sensitive Skin Syndrome: An Algorithm for Clinical Practice (cid:2)

  year unknowncites this paper